Strange PG - Search Results

1

Mechanisms of inverse agonism at G-protein-coupled receptors.

Strange PG. Strange PG. Trends Pharmacol Sci. 2002 Feb;23(2):89-95. doi: 10.1016/s0165-6147(02)01993-4. Trends Pharmacol Sci. 2002. PMID: 11830266 Review.

2

Examining the Effects of Sodium Ions on the Binding of Antagonists to Dopamine D2 and D3 Receptors.

Newton CL, Wood MD, Strange PG. Newton CL, et al. Among authors: strange pg. PLoS One. 2016 Jul 5;11(7):e0158808. doi: 10.1371/journal.pone.0158808. eCollection 2016. PLoS One. 2016. PMID: 27379794 Free PMC article.

3

Co-operativity in agonist binding at the D2 dopamine receptor: evidence from agonist dissociation kinetics.

Kara E, Lin H, Strange PG. Kara E, et al. Among authors: strange pg. J Neurochem. 2010 Mar;112(6):1442-53. doi: 10.1111/j.1471-4159.2009.06554.x. Epub 2009 Dec 24. J Neurochem. 2010. PMID: 20050980 Free article.

4

Analysis of the actions of the novel dopamine receptor-directed compounds (S)-OSU6162 and ACR16 at the D2 dopamine receptor.

Kara E, Lin H, Svensson K, Johansson AM, Strange PG. Kara E, et al. Among authors: strange pg. Br J Pharmacol. 2010 Nov;161(6):1343-50. doi: 10.1111/j.1476-5381.2010.01010.x. Br J Pharmacol. 2010. PMID: 20804495 Free PMC article.

5

Use of the GTPγS ([35S]GTPγS and Eu-GTPγS) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors.

Strange PG. Strange PG. Br J Pharmacol. 2010 Nov;161(6):1238-49. doi: 10.1111/j.1476-5381.2010.00963.x. Br J Pharmacol. 2010. PMID: 20662841 Free PMC article. Review.

6

Antipsychotic drug action: antagonism, inverse agonism or partial agonism.

Strange PG. Strange PG. Trends Pharmacol Sci. 2008 Jun;29(6):314-21. doi: 10.1016/j.tips.2008.03.009. Epub 2008 May 28. Trends Pharmacol Sci. 2008. PMID: 18471899 Review.

7

Signaling mechanisms of GPCR ligands.

Strange PG. Strange PG. Curr Opin Drug Discov Devel. 2008 Mar;11(2):196-202. Curr Opin Drug Discov Devel. 2008. PMID: 18283607 Review.

8

Allosteric effects of antagonists on signalling by the chemokine receptor CCR5.

Haworth B, Lin H, Fidock M, Dorr P, Strange PG. Haworth B, et al. Among authors: strange pg. Biochem Pharmacol. 2007 Sep 15;74(6):891-7. doi: 10.1016/j.bcp.2007.06.032. Epub 2007 Jun 26. Biochem Pharmacol. 2007. PMID: 17669370

9

CCL3, acting via the chemokine receptor CCR5, leads to independent activation of Janus kinase 2 (JAK2) and Gi proteins.

Mueller A, Strange PG. Mueller A, et al. Among authors: strange pg. FEBS Lett. 2004 Jul 16;570(1-3):126-32. doi: 10.1016/j.febslet.2004.04.100. FEBS Lett. 2004. PMID: 15251452

10

Mechanisms of agonist action at D2 dopamine receptors.

Roberts DJ, Lin H, Strange PG. Roberts DJ, et al. Among authors: strange pg. Mol Pharmacol. 2004 Dec;66(6):1573-9. doi: 10.1124/mol.104.004077. Epub 2004 Aug 31. Mol Pharmacol. 2004. PMID: 15340043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results